Table 2.
Strain | Log10 reduction in survival of bacterial cells after treatment witha: |
||||||||
---|---|---|---|---|---|---|---|---|---|
RB |
PEX |
RB+PEX |
Light only | Antibiotic resistance statusb | |||||
Light | Dark | Light | Dark | Light | Dark | ||||
1 | 10145 | 0.21 | 0.13 | 3.34 | 2.70 | 5.69 | 2.68 | 0.20 | |
2 | 3042/s | 0.44 | −0.12 | 6.45 | 6.45 | 6.45 | 6.45 | 0.03 | |
3 | 3318/p | 0.48 | −0.01 | 5.82 | 5.82 | 5.82 | 5.82 | 0.14 | |
4 | 2969/s | 0.35 | 0.25 | 6.12 | 4.49 | 6.12 | 6.12 | 0.20 | |
5 | 1561/o | 1.11 | 0.14 | 1.46 | 1.33 | 5.37 | 2.25 | 0.42 | MDR |
6 | 3404/p | 0.81 | 0.03 | 5.37 | 5.37 | 5.37 | 5.37 | 0.36 | |
7 | 3117/s | 0.35 | 0.19 | 6.04 | 6.04 | 6.04 | 6.04 | 0.30 | |
8 | 3146/s | 0.63 | 0.18 | 1.97 | 1.48 | 5.90 | 2.18 | 0.43 | |
9 | 4190/p A | 0.58 | 0.41 | 3.44 | 2.61 | 6.43 | 3.07 | 0.54 | MDR |
10 | 1959/o | 0.43 | 0.21 | 0.98 | 0.85 | 5.05 | 5.05 | 0.12 | XDR |
11 | 3109/o | −0.08 | −0.11 | 5.13 | 5.13 | 5.13 | 5.13 | 0.01 | MDR |
12 | 1286/o | 0.36 | 0.24 | 0.56 | 0.55 | 5.42 | 2.70 | 0.19 | |
13 | 55/K | 0.44 | 0.24 | 5.27 | 5.27 | 5.27 | 5.27 | 0.21 | XDR |
14 | 978/K | 0.69 | −0.08 | 5.75 | 2.79 | 5.75 | 5.75 | 0.49 | XDR |
15 | K3 | 1.10 | 0.14 | 5.95 | 5.95 | 5.95 | 5.95 | 0.02 | MDR |
16 | K4 | 0.12 | 0.05 | 6.04 | 6.04 | 6.04 | 6.04 | 0.07 | XDR |
17 | 792/K | 1.16 | 0.20 | 5.14 | 5.14 | 5.14 | 5.14 | 0.37 | MDR |
18 | 393/K | 1.54 | 0.19 | 5.17 | 2.87 | 5.17 | 2.77 | 0.31 | |
19 | 133/K | −0.10 | 0.00 | 0.23 | 0.31 | 5.02 | 3.22 | 0.02 | |
20 | 23/K | 0.90 | 0.23 | 0.67 | 0.55 | 5.90 | 5.90 | 0.49 | |
21 | 887/K | 0.68 | 0.34 | 5.62 | 5.62 | 5.62 | 5.62 | 0.49 | XDR |
22 | 169/K | 2.06 | −0.02 | 2.37 | 0.52 | 5.98 | 5.98 | 0.07 | XDR |
23 | 3752/sz | 1.12 | 0.14 | 5.85 | 5.85 | 5.85 | 5.85 | 0.05 | |
24 | 4908/p | 0.02 | −0.37 | 1.96 | 1.63 | 4.88 | 2.07 | 0.00 | |
25 | 3907/sz | 0.92 | 0.07 | 3.09 | 2.37 | 5.29 | 3.56 | 0.86 | |
26 | 15/p I | 1.12 | 0.32 | 5.64 | 5.64 | 5.64 | 5.64 | 0.16 | |
27 | 149/p | 0.78 | 0.44 | 0.46 | 0.47 | 5.97 | 2.64 | 0.49 | |
28 | 153/s | 0.20 | 0.10 | 0.49 | 0.35 | 6.44 | 3.38 | 0.20 | |
29 | 547/p | 0.37 | 0.48 | 2.89 | 1.64 | 5.81 | 4.02 | 0.14 | |
30 | 1885/K | 0.79 | 0.51 | 1.12 | 0.83 | 6.05 | 2.04 | 0.09 | XDR |
31 | 556/K | 0.46 | 0.29 | 0.67 | 0.27 | 5.41 | 1.93 | 0.25 | XDR |
32 | 1651/p | 0.74 | 0.22 | 0.46 | −0.28 | 5.46 | 2.42 | 0.03 | |
33 | 1304/s | 1.25 | 0.33 | 5.70 | 5.70 | 5.70 | 5.70 | 0.65 | MDR |
34 | 1804/p | 1.08 | 0.01 | 5.26 | 2.60 | 5.26 | 2.37 | 0.25 | |
35 | 2284/p | 0.87 | 0.41 | 1.04 | 0.97 | 5.38 | 2.14 | 0.09 | |
36 | 143/p | 0.93 | 0.50 | 2.95 | 2.27 | 5.83 | 3.07 | 0.61 |
aThe values were calculated by subtracting log10 CFU/ml of treated samples from those of untreated controls (0 J/cm2; 0 μM RB, 0 μM PEX). The following concentration of compounds was used: 5 μM RB, 5 μM PEX, fluence 30 J/cm2. The initial number of cells was ∼106 CFU/ml. The presented values are mean of three independent experiments. bMDR (multidrug resistant), XDR (extended drug resistant), see Section “Materials and Methods” for classification details.